Clinical Trials Logo

Poikiloderma of Civatte clinical trials

View clinical trials related to Poikiloderma of Civatte.

Filter by:
  • None
  • Page 1

NCT ID: NCT04581330 Completed - Clinical trials for Poikiloderma of Civatte

The Effects of Fractional CO2 Laser on Poikiloderma of Civatte

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

This study will assess the safety and efficacy of fractional CO2 laser treatment for Poikiloderma of Civatte (POC).POC is a chronic vascular and pigmentary disorder typically involving the lateral and inferior neck region, as well as the chest area. Clinically, poikiloderma appears as a combination of telangiectasia, irregular pigmentation, and atrophic changes.Little data exist regarding the use of fractional CO2 laser for management of POC. This study hopes to fulfill this purpose. The primary outcome will be a blinded assessment by dermatologists in the improvement in POC using the Physician's Global Aesthetic Improvement Scale following therapy. The secondary outcomes include subject satisfaction post-treatment and assessment of all procedure-related adverse events.

NCT ID: NCT01491620 Completed - Telangiectasia Clinical Trials

Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte

Start date: November 2011
Phase: N/A
Study type: Interventional

This study will evaluate the safety and efficacy of the Excel V 532 nm KTP laser for the treatment of dyschromia of the neck and/or chest (poikiloderma of Civatte).